Bausch & Lomb upgraded to Outperform at Evercore - MSN

Bausch & Lomb (NYSE:BLCO) was upgraded to Outperform from In Line at Evercore ISI on reports of potential buyout by TPG & Blackstone.PT is updated to $25 from $19. The …

$25
OFF

Bausch & Lomb Upgraded To Outperform At Evercore - MSN

2 weeks from now

Bausch & Lomb (NYSE:BLCO) was upgraded to Outperform from In Line at Evercore ISI on reports of potential buyout by TPG & Blackstone.PT is updated to $25 from $19. The …

msn.com

88%
OFF

Evercore ISI Group Upgrades Bausch + Lomb (BLCO) | Nasdaq

2 weeks from now

Sep 24, 2024 · Fintel reports that on October 15, 2024, Evercore ISI Group upgraded their outlook for Bausch + Lomb from In-Line to Outperform.. Analyst Price Forecast Suggests 2.88% …

nasdaq.com

$19.00
OFF

HC Wainwright Reiterates Buy Rating For Bausch + Lomb

2 weeks from now

Dec 12, 2024 · Finally, Evercore ISI upgraded Bausch + Lomb from an "in-line" rating to an "outperform" rating and boosted their target price for the company from $19.00 to $25.00 in a …

marketbeat.com

$19.00
OFF

Bausch + Lomb (NYSE:BLCO) Downgraded By Morgan Stanley To …

2 weeks from now

Dec 3, 2024 · Evercore ISI upgraded shares of Bausch + Lomb from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $19.00 to $25.00 in a …

americanbankingnews.com

51%
OFF

Evercore ISI Group Upgrades Bausch + Lomb (TSX:BLCO) - Fintel

2 weeks from now

Oct 16, 2024 · Fintel reports that on October 15, 2024, Evercore ISI Group upgraded their outlook for Bausch + Lomb from In-Line to Outperform. Analyst Price Forecast Suggests 4.51% …

fintel.io

$25
OFF

Bausch + Lomb Upgraded To Outperform From In Line At Evercore ISI

2 weeks from now

Evercore ISI analyst Vijay Kumar upgraded Bausch + Lomb to Outperform from In Line with a $25 price target Published first on TheFly – the ultimate source for real-time, market-moving …

tipranks.com

$22
OFF

Bausch + Lomb Price Target Lowered To $22 From $25 At Evercore ISI

2 weeks from now

Jan 2, 2025 · Evercore ISI lowered the firm’s price target on Bausch + Lomb (BLCO) to $22 from $25 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for …

yahoo.com

$19.00
OFF

Bausch + Lomb (NYSE:BLCO) Downgraded To Equal Weight Rating …

2 weeks from now

Dec 3, 2024 · Evercore ISI upgraded shares of Bausch + Lomb from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $19.00 to $25.00 in a …

defenseworld.net

$19
OFF

Bausch + Lomb Price Target Raised To $19 From $17 At Evercore ISI

2 weeks from now

Oct 2, 2024 · Evercore ISI raised the firm’s price target on Bausch + Lomb to $19 from $17 and keeps an In Line rating on the shares. In MedTech, utilization remains positive into Q3 and the …

yahoo.com

$23
OFF

Bausch + Lomb Price Target Raised To $23 From $20 At RBC Capital

2 weeks from now

Oct 22, 2024 · Bausch + Lomb upgraded to Outperform from In Line at Evercore ISI M&A News: TPG and Blackstone Could Eye Joint Bid for Bausch + Lomb (NYSE:BLCO) Boeing to cut …

nasdaq.com

FAQs about Bausch & Lomb upgraded to Outperform at Evercore - MSN Coupon?

Should you buy Bausch & Lomb (BLCO) in 2024?

F intel reports that on October 15, 2024, Evercore ISI Group upgraded their outlook for Bausch + Lomb (NYSE:BLCO) from In-Line to Outperform. Analyst Price Forecast Suggests 2.88% Downside As of September 24, 2024, the average one-year price target for Bausch + Lomb is $20.14/share. The forecasts range from a low of $17.17 to a high of $26.25. ...

Should you buy Bausch & Lomb Corporation (B&L)?

Currently, the analyst consensus on Bausch + Lomb Corporation is a Moderate Buy with an average price target of $20.50, representing a -1.77% downside. In a report released yesterday, Wells Fargo also assigned a Buy rating to the stock with a $23.00 price target. ...

What is the average price target for Bausch & Lomb?

As of September 24, 2024, the average one-year price target for Bausch + Lomb is $20.14/share. The forecasts range from a low of $17.17 to a high of $26.25. The average price target represents a decrease of 2.88% from its latest reported closing price of $20.74 / share. See our leaderboard of companies with the largest price target upside. ...

Should you buy Bausch & Lomb Corporation (BLCO) stock?

Wells Fargo analyst Larry Biegelsen has maintained their bullish stance on BLCO stock, giving a Buy rating on October 22. Larry Biegelsen’s rating is based on several positive trends and projections for Bausch + Lomb Corporation. ...

Will Bausch & Lomb keep its 2024 sales guidance?

Biegelsen sees the company’s 2024 sales guidance as attainable, supported by robust market growth and effective execution. Moreover, Biegelsen anticipates that Bausch + Lomb will maintain its sales guidance for key products, with potential pricing benefits as payer coverage improves. ...

How many funds own Bausch & Lomb?

There are 122 funds or institutions reporting positions in Bausch + Lomb. This is an increase of 4 owner (s) or 3.39% in the last quarter. Average portfolio weight of all funds dedicated to BLCO is 0.35%, an increase of 7.29%. Total shares owned by institutions increased in the last three months by 7.18% to 43,757K shares. ...